{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:23:51Z","timestamp":1790987031854,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00277-021-04629-2","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T06:03:58Z","timestamp":1629439438000},"page":"2979-2988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value"],"prefix":"10.1007","volume":"100","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-6606","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"4629_CR1","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/ncomms3997","volume":"5","author":"N Bolli","year":"2014","unstructured":"Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I et al (2014) Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun 5:2997. https:\/\/doi.org\/10.1038\/ncomms3997","journal-title":"Nat Commun"},{"key":"4629_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","volume":"15","author":"SK Kumar","year":"2018","unstructured":"Kumar SK, Rajkumar SV (2018) The multiple myelomas - current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol 15:409\u2013421. https:\/\/doi.org\/10.1038\/s41571-018-0018-y","journal-title":"Nat Rev Clin Oncol"},{"key":"4629_CR3","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa070389","volume":"356","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM et al (2007) Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med 356:2582\u20132590. https:\/\/doi.org\/10.1056\/NEJMoa070389","journal-title":"N Engl J Med"},{"key":"4629_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR et al (2018) Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med 378:241\u2013249. https:\/\/doi.org\/10.1056\/NEJMoa1709974","journal-title":"N Engl J Med"},{"key":"4629_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"International Myeloma Working G","year":"2003","unstructured":"International Myeloma Working G (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749\u2013757","journal-title":"Br J Haematol"},{"key":"4629_CR6","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/s1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos M-V et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548. https:\/\/doi.org\/10.1016\/s1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"4629_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","volume":"33","author":"C Nanni","year":"2006","unstructured":"Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D et al (2006) Role of 18F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging 33:525\u2013531. https:\/\/doi.org\/10.1007\/s00259-005-0004-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4629_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3324\/haematol.10554","volume":"92","author":"E Zamagni","year":"2007","unstructured":"Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O et al (2007) A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 92:50\u201355","journal-title":"Haematologica"},{"key":"4629_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3324\/haematol.2012.066555","volume":"98","author":"S Waheed","year":"2013","unstructured":"Waheed S, Mitchell A, Usmani S, Epstein J, Yaccoby S, Nair B et al (2013) Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data. Haematologica 98:71\u201378. https:\/\/doi.org\/10.3324\/haematol.2012.066555","journal-title":"Haematologica"},{"key":"4629_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2967\/jnumed.112.106500","volume":"53","author":"R Fonti","year":"2012","unstructured":"Fonti R, Larobina M, Del Vecchio S, De Luca S, Fabbricini R, Catalano L et al (2012) Metabolic tumor volume assessed by 18F-FDG PET\/CT for the prediction of outcome in patients with multiple myeloma. J Nucl Med 53:1829\u20131835. https:\/\/doi.org\/10.2967\/jnumed.112.106500","journal-title":"J Nucl Med"},{"key":"4629_CR11","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1158\/1078-0432.CCR-16-0235","volume":"23","author":"JE McDonald","year":"2017","unstructured":"McDonald JE, Kessler MM, Gardner MW, Buros AF, Ntambi JA, Waheed S et al (2017) Assessment of total lesion glycolysis by (18)F FDG PET\/CT significantly improves prognostic value of GEP and ISS in myeloma. Clin Cancer Res 23:1981\u20131987. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0235","journal-title":"Clin Cancer Res"},{"key":"4629_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood-2018-04-842880","volume":"132","author":"L Rasche","year":"2018","unstructured":"Rasche L, Angtuaco EJ, Alpe TL, Gershner GH, McDonald JE, Samant RS et al (2018) The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma. Blood 132:59\u201366. https:\/\/doi.org\/10.1182\/blood-2018-04-842880","journal-title":"Blood"},{"key":"4629_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","volume":"114","author":"TB Bartel","year":"2009","unstructured":"Bartel TB, Haessler J, Brown TL, Shaughnessy JD Jr, van Rhee F, Anaissie E et al (2009) F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood 114:2068\u20132076. https:\/\/doi.org\/10.1182\/blood-2009-03-213280","journal-title":"Blood"},{"key":"4629_CR14","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1182\/blood-2011-06-361386","volume":"118","author":"E Zamagni","year":"2011","unstructured":"Zamagni E, Patriarca F, Nanni C, Zannetti B, Englaro E, Pezzi A et al (2011) Prognostic relevance of 18-F FDG PET\/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood 118:5989\u20135995. https:\/\/doi.org\/10.1182\/blood-2011-06-361386","journal-title":"Blood"},{"key":"4629_CR15","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","volume":"35","author":"P Moreau","year":"2017","unstructured":"Moreau P, Attal M, Caillot D, Macro M, Karlin L, Garderet L et al (2017) Prospective evaluation of magnetic resonance imaging and [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM\/DFCI 2009 trial: results of the IMAJEM study. J Clin Oncol 35:2911\u20132918. https:\/\/doi.org\/10.1200\/JCO.2017.72.2975","journal-title":"J Clin Oncol"},{"key":"4629_CR16","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S et al (2017) Role of (18)F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol 18:e206\u2013e217. https:\/\/doi.org\/10.1016\/S1470-2045(17)30189-4","journal-title":"Lancet Oncol"},{"key":"4629_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00259-017-3730-4","volume":"44","author":"C Nanni","year":"2017","unstructured":"Nanni C, Zamagni E (2017) Therapy assessment in multiple myeloma with PET. Eur J Nucl Med Mol Imaging 44:111\u2013117. https:\/\/doi.org\/10.1007\/s00259-017-3730-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4629_CR18","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.clml.2013.12.014","volume":"14","author":"E Zamagni","year":"2014","unstructured":"Zamagni E, Nanni C, Tacchetti P, Pantani L, Marzocchi G, Zannetti B et al (2014) Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. Clin Lymphoma Myeloma Leuk 14:e101-104. https:\/\/doi.org\/10.1016\/j.clml.2013.12.014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4629_CR19","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P et al (2016) International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 17:e328\u2013e346. https:\/\/doi.org\/10.1016\/S1470-2045(16)30206-6","journal-title":"Lancet Oncol"},{"key":"4629_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00259-015-3200-9","volume":"43","author":"C Nanni","year":"2016","unstructured":"Nanni C, Zamagni E, Versari A, Chauvie S, Bianchi A, Rensi M et al (2016) Image interpretation criteria for FDG PET\/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe). Eur J Nucl Med Mol Imaging 43:414\u2013421. https:\/\/doi.org\/10.1007\/s00259-015-3200-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4629_CR21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00259-017-3909-8","volume":"45","author":"C Nanni","year":"2018","unstructured":"Nanni C, Versari A, Chauvie S, Bertone E, Bianchi A, Rensi M et al (2018) Interpretation criteria for FDG PET\/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). Eur J Nucl Med Mol Imaging 45:712\u2013719. https:\/\/doi.org\/10.1007\/s00259-017-3909-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4629_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1200\/JCO.20.00386","volume":"39","author":"E Zamagni","year":"2021","unstructured":"Zamagni E, Nanni C, Dozza L, Carlier T, Bailly C, Tacchetti P et al (2021) Standardization of (18)F-FDG-PET\/CT according to deauville criteria for metabolic complete response definition in newly diagnosed multiple myeloma. J Clin Oncol 39:116\u2013125. https:\/\/doi.org\/10.1200\/JCO.20.00386","journal-title":"J Clin Oncol"},{"key":"4629_CR23","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00330-016-4543-8","volume":"27","author":"SY Lee","year":"2017","unstructured":"Lee SY, Kim HJ, Shin YR, Park HJ, Lee YG, Oh SJ (2017) Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis. Eur Radiol 27:2333\u20132347. https:\/\/doi.org\/10.1007\/s00330-016-4543-8","journal-title":"Eur Radiol"},{"key":"4629_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/bjh.12820","volume":"165","author":"MK Song","year":"2014","unstructured":"Song MK, Chung JS, Lee JJ, Min CK, Ahn JS, Lee SM et al (2014) Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation. Br J Haematol 165:777\u2013785. https:\/\/doi.org\/10.1111\/bjh.12820","journal-title":"Br J Haematol"},{"key":"4629_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1148\/radiol.2016160363","volume":"282","author":"V Koutoulidis","year":"2017","unstructured":"Koutoulidis V, Fontara S, Terpos E, Zagouri F, Matsaridis D, Christoulas D et al (2017) Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse mr imaging pattern in patients with multiple myeloma. Radiology 282:484\u2013493. https:\/\/doi.org\/10.1148\/radiol.2016160363","journal-title":"Radiology"},{"key":"4629_CR26","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.ejrad.2014.09.012","volume":"83","author":"C Mesguich","year":"2014","unstructured":"Mesguich C, Fardanesh R, Tanenbaum L, Chari A, Jagannath S, Kostakoglu L (2014) State of the art imaging of multiple myeloma: comparative review of FDG PET\/CT imaging in various clinical settings. Eur J Radiol 83:2203\u20132223. https:\/\/doi.org\/10.1016\/j.ejrad.2014.09.012","journal-title":"Eur J Radiol"},{"key":"4629_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ajh.23258","volume":"87","author":"LA Moulopoulos","year":"2012","unstructured":"Moulopoulos LA, Dimopoulos MA, Kastritis E, Christoulas D, Gkotzamanidou M, Roussou M et al (2012) Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients. Am J Hematol 87:861\u2013864. https:\/\/doi.org\/10.1002\/ajh.23258","journal-title":"Am J Hematol"},{"key":"4629_CR28","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s00330-016-4543-8","volume":"27","author":"SYKH Lee","year":"2017","unstructured":"Lee SYKH, Shin YR, Park HJ, Lee YG, Oh SJ (2017) Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis. Eur Radiol 27:2333\u20132347. https:\/\/doi.org\/10.1007\/s00330-016-4543-8","journal-title":"Eur Radiol"},{"key":"4629_CR29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ejrad.2014.03.005","volume":"83","author":"M Andrulis","year":"2014","unstructured":"Andrulis M, Bauerle T, Goldschmidt H, Delorme S, Landgren O, Schirmacher P et al (2014) Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology. Eur J Radiol 83:970\u2013974. https:\/\/doi.org\/10.1016\/j.ejrad.2014.03.005","journal-title":"Eur J Radiol"},{"key":"4629_CR30","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1200\/JCO.2009.25.5356","volume":"28","author":"J Hillengass","year":"2010","unstructured":"Hillengass J, Fechtner K, Weber MA, Bauerle T, Ayyaz S, Heiss C et al (2010) Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 28:1606\u20131610. https:\/\/doi.org\/10.1200\/JCO.2009.25.5356","journal-title":"J Clin Oncol"},{"key":"4629_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","volume":"33","author":"MA Dimopoulos","year":"2015","unstructured":"Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE et al (2015) Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 33:657\u2013664. https:\/\/doi.org\/10.1200\/JCO.2014.57.9961","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04629-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04629-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T14:04:29Z","timestamp":1636985069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04629-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4629"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04629-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"9 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants for the use of their anonymized medical records for research purpose. The study was approved by the Ethics Committee of Zhongshan Hospital, Fudan University (B2017-031R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}